Cancer Research Targets Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, J.
Right arrow Articles by Reed, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, J.
Right arrow Articles by Reed, S. G.
[Cancer Research 60, 1677-1682, March 15, 2000]
© 2000 American Association for Cancer Research

Molecular Biology and Genetics

Identification of Differentially Expressed Genes in Human Prostate Cancer Using Subtraction and Microarray1

Jiangchun Xu2, John A. Stolk, Xinqun Zhang, Sandra J. Silva, Raymond L. Houghton, Masazumi Matsumura, Thomas S. Vedvick, Kevin B. Leslie, Roberto Badaro and Steven G. Reed

Corixa Corporation, Seattle, Washington 98104 [J. X., J. A. S., X. Z., S. J. S., R. L. H., M. M., T. S. V., S. G. R.]; ImmGenics Pharmaceuticals Inc., Vancouver, British Columbia, V67 123 Canada [K. B. L.]; Department of Infectious Disease, Federal University of Bahia, Salvador, Bahia, Brazil [R. B.]; and Department of Pathobiology, University of Washington, Seattle, Washington 98195 [S. G. R.]

We have identified human prostate cancer- and tissue-specific genes using cDNA library subtraction in conjunction with high throughput microarray screening. Subtracted cDNA libraries of prostate tumors and normal prostate tissue were generated. Characterization of subtracted libraries showed enrichment of both cancer- and tissue-specific genes. Highly redundant clones were eliminated by colony hybridization. The remaining clones were selected for microarray to determine gene expression levels in a variety of tumor and normal tissues. Clones showing overexpression in prostate tumors and/or normal prostate tissues were selected and sequenced. Here we report the identification of two genes, P503S and P504S, from subtracted libraries and a third gene, P510S, by subtraction followed by microarray screening. Their expression profiles were further confirmed by Northern blot, real-time PCR (TaqMan), and immunohistochemistry to be overexpressed in prostate tissues and/or prostate tumors. Full-length cDNA sequences were cloned, and their subcellular locations were predicted by a bioinformatic algorithm, PSORT, to be plasma membrane proteins. The genes identified through these approaches are potential candidates for cancer diagnosis and therapy.




This article has been cited by other articles:


Home page
 Anticancer ResHome page
K. TAKAHARA, H. AZUMA, T. SAKAMOTO, S. KIYAMA, T. INAMOTO, N. IBUKI, T. NISHIDA, H. NOMI, T. UBAI, N. SEGAWA, et al.
Conversion of Prostate Cancer from Hormone Independency to Dependency Due to AMACR Inhibition: Involvement of Increased AR Expression and Decreased IGF1 Expression
Anticancer Res, July 1, 2009; 29(7): 2497 - 2505.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
B. P. Mello, E. F. Abrantes, C. H. Torres, A. Machado-Lima, R. d. S. Fonseca, D. M. Carraro, R. R. Brentani, L. F. L. Reis, and H. Brentani
No-match ORESTES explored as tumor markers
Nucleic Acids Res., May 1, 2009; 37(8): 2607 - 2617.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. H. Cho-Vega, S. Tsavachidis, K.-A. Do, J. Nakagawa, L. J. Medeiros, and T. J. McDonnell
Dicarbonyl/L-Xylulose Reductase: A Potential Biomarker Identified by Laser-Capture Microdissection-Micro Serial Analysis of Gene Expression of Human Prostate Adenocarcinoma
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2615 - 2622.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
Li Chen, Zhiwei Wang, Xi Zhan, D.-C. Li, Y.-Y. Zhu, and Jianwei Zhu
Association of NET-1 Gene Expression With Human Hepatocellular Carcinoma
International Journal of Surgical Pathology, October 1, 2007; 15(4): 346 - 353.
[Abstract] [PDF]

Home page
 Am. J. Pathol.Home page
J. R. Pollack
A Perspective on DNA Microarrays in Pathology Research and Practice
Am. J. Pathol., August 1, 2007; 171(2): 375 - 385.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
J. Stewart, N. Fleshner, H. Cole, and J. Sweet
Comparison of annexin II, p63 and {alpha}-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study
J. Clin. Pathol., July 1, 2007; 60(7): 773 - 780.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Xu, S. Cheepala, E. McCauley, K. Coombes, L. Xiao, S. M. Fischer, and J. L. Clifford
Chemoprevention of Skin Carcinogenesis by Phenylretinamides: Retinoid Receptor-Independent Tumor Suppression
Clin. Cancer Res., February 1, 2006; 12(3): 969 - 979.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
P. R. Nambiar, S. R. Boutin, R. Raja, and D. W. Rosenberg
Global Gene Expression Profiling: A Complement to Conventional Histopathologic Analysis of Neoplasia
Vet. Pathol., November 1, 2005; 42(6): 735 - 752.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Konishi, M. Nakamura, E. Ishida, K. Shimada, E. Mitsui, R. Yoshikawa, H. Yamamoto, and K. Tsujikawa
High Expression of a New Marker PCA-1 in Human Prostate Carcinoma
Clin. Cancer Res., July 15, 2005; 11(14): 5090 - 5097.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. A. Rubin, T. A. Bismar, O. Andren, L. Mucci, R. Kim, R. Shen, D. Ghosh, J. T. Wei, A. M. Chinnaiyan, H.-O. Adami, et al.
Decreased {alpha}-Methylacyl CoA Racemase Expression in Localized Prostate Cancer is Associated with an Increased Rate of Biochemical Recurrence and Cancer-Specific Death
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1424 - 1432.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Kortesidis, A. Zannettino, S. Isenmann, S. Shi, T. Lapidot, and S. Gronthos
Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells
Blood, May 15, 2005; 105(10): 3793 - 3801.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
A. N. Schuetz, Q. Yin-Goen, M. B. Amin, C. S. Moreno, C. Cohen, C. D. Hornsby, W. L. Yang, J. A. Petros, M. M. Issa, J. G. Pattaras, et al.
Molecular Classification of Renal Tumors by Gene Expression Profiling
J. Mol. Diagn., May 1, 2005; 7(2): 206 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Liu, P. S. Rudland, D. R. Sibson, A. Platt-Higgins, and R. Barraclough
Human Homologue of Cement Gland Protein, a Novel Metastasis Inducer Associated with Breast Carcinomas
Cancer Res., May 1, 2005; 65(9): 3796 - 3805.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
R. Foley, D. Hollywood, and M. Lawler
Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease
Endocr. Relat. Cancer, September 1, 2004; 11(3): 477 - 488.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. Sreekumar, B. Laxman, D. R. Rhodes, S. Bhagavathula, J. Harwood, D. Giacherio, D. Ghosh, M. G. Sanda, M. A. Rubin, and A. M. Chinnaiyan
Humoral Immune Response to {alpha}-Methylacyl-CoA Racemase and Prostate Cancer
J Natl Cancer Inst, June 2, 2004; 96(11): 834 - 843.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. A. Rubin, M. P. Zerkowski, R. L. Camp, R. Kuefer, M. D. Hofer, A. M. Chinnaiyan, and D. L. Rimm
Quantitative Determination of Expression of the Prostate Cancer Protein {alpha}-Methylacyl-CoA Racemase Using Automated Quantitative Analysis (AQUA): A Novel Paradigm for Automated and Continuous Biomarker Measurements
Am. J. Pathol., March 1, 2004; 164(3): 831 - 840.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Amatschek, U. Koenig, H. Auer, P. Steinlein, M. Pacher, A. Gruenfelder, G. Dekan, S. Vogl, E. Kubista, K.-H. Heider, et al.
Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes
Cancer Res., February 1, 2004; 64(3): 844 - 856.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
A J Evans
{alpha}-Methylacyl CoA racemase (P504S): overview and potential uses in diagnostic pathology as applied to prostate needle biopsies
J. Clin. Pathol., December 1, 2003; 56(12): 892 - 897.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Zha, S. Ferdinandusse, S. Denis, R. J. Wanders, C. M. Ewing, J. Luo, A. M. De Marzo, and W. B. Isaacs
{alpha}-Methylacyl-CoA Racemase as an Androgen-Independent Growth Modifier in Prostate Cancer
Cancer Res., November 1, 2003; 63(21): 7365 - 7376.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Mobley, I. Leav, P. Zielie, C. Wotkowitz, J. Evans, Y.-W. Lam, B. S. L'Esperance, Z. Jiang, and S.-M. Ho
Branched Fatty Acids in Dairy and Beef Products Markedly Enhance {alpha}-Methylacyl-CoA Racemase Expression in Prostate Cancer Cells in Vitro
Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 775 - 783.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
W.A. Schulz, M. Burchardt, and M.V. Cronauer
Molecular biology of prostate cancer
Mol. Hum. Reprod., August 1, 2003; 9(8): 437 - 448.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. L. Shen-Ong, Y. Feng, and D. A. Troyer
Expression Profiling Identifies a Novel {alpha}-Methylacyl-CoA Racemase Exon with Fumarate Hydratase Homology
Cancer Res., June 15, 2003; 63(12): 3296 - 3301.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
Y. Li, X. Li, and F. H. Sarkar
Gene Expression Profiles of I3C- and DIM-Treated PC3 Human Prostate Cancer Cells Determined by cDNA Microarray Analysis
J. Nutr., April 1, 2003; 133(4): 1011 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Santamaria, P. L. Fernandez, X. Farre, P. Benedit, J. Reventos, J. Morote, R. Paciucci, and T. M. Thomson
PTOV-1, a Novel Protein Overexpressed in Prostate Cancer, Shuttles between the Cytoplasm and the Nucleus and Promotes Entry into the S Phase of the Cell Division Cycle
Am. J. Pathol., March 1, 2003; 162(3): 897 - 905.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
Y. Li and F. H. Sarkar
Gene Expression Profiles of Genistein-Treated PC3 Prostate Cancer Cells
J. Nutr., December 1, 2002; 132(12): 3623 - 3631.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. L. Zheng, B.-l. Chang, D. A. Faith, J. R. Johnson, S. D. Isaacs, G. A. Hawkins, A. Turner, K. E. Wiley, E. R. Bleecker, P. C. Walsh, et al.
Sequence Variants of {alpha}-Methylacyl-CoA Racemase Are Associated with Prostate Cancer Risk
Cancer Res., November 15, 2002; 62(22): 6485 - 6488.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. L. Dennis, J. K. Vass, E. C. Wit, W. N. Keith, and K. A. Oien
Identification from Public Data of Molecular Markers of Adenocarcinoma Characteristic of the Site of Origin
Cancer Res., November 1, 2002; 62(21): 5999 - 6005.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. Karan, D. L. Kelly, A. Rizzino, M.-F. Lin, and S. K. Batra
Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells
Carcinogenesis, June 1, 2002; 23(6): 967 - 976.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. W. Asmann, F. Kosari, K. Wang, J. C. Cheville, and G. Vasmatzis
Identification of Differentially Expressed Genes in Normal and Malignant Prostate by Electronic Profiling of Expressed Sequence Tags
Cancer Res., June 1, 2002; 62(11): 3308 - 3314.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Xu, F. M. Selaru, J. Yin, T. T. Zou, V. Shustova, Y. Mori, F. Sato, T. C. Liu, A. Olaru, S. Wang, et al.
Artificial Neural Networks and Gene Filtering Distinguish Between Global Gene Expression Profiles of Barrett's Esophagus and Esophageal Cancer
Cancer Res., June 1, 2002; 62(12): 3493 - 3497.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Luo, S. Zha, W. R. Gage, T. A. Dunn, J. L. Hicks, C. J. Bennett, C. M. Ewing, E. A. Platz, S. Ferdinandusse, R. J. Wanders, et al.
{alpha}-Methylacyl-CoA Racemase: A New Molecular Marker for Prostate Cancer
Cancer Res., April 1, 2002; 62(8): 2220 - 2226.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
C. Rosenow, R. M. Saxena, M. Durst, and T. R. Gingeras
Prokaryotic RNA preparation methods useful for high density array analysis: comparison of two approaches
Nucleic Acids Res., November 15, 2001; 29(22): e112 - e112.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
H. C. King and A. A. Sinha
Gene Expression Profile Analysis by DNA Microarrays: Promise and Pitfalls
JAMA, November 14, 2001; 286(18): 2280 - 2288.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Masui, R. Hosotani, S. Tsuji, Y. Miyamoto, S. Yasuda, J. Ida, S. Nakajima, M. Kawaguchi, H. Kobayashi, M. Koizumi, et al.
Expression of METH-1 and METH-2 in Pancreatic Cancer
Clin. Cancer Res., November 1, 2001; 7(11): 3437 - 3443.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S.-Y. Xiao, H. L. Wang, J. Hart, D. Fleming, and M. R. Beard
cDNA Arrays and Immunohistochemistry Identification of CD10/CALLA Expression in Hepatocellular Carcinoma
Am. J. Pathol., October 1, 2001; 159(4): 1415 - 1421.
[Abstract] [Full Text]

Home page
 Nucleic Acids ResHome page
A. V. Lichtenstein, O.'g. I. Serdjuk, T. I. Sukhova, H. S. Melkonyan, and S. R. Umansky
Selective 'stencil'-aided pre-PCR cleavage of wild-type sequences as a novel approach to detection of mutant K-RAS
Nucleic Acids Res., September 1, 2001; 29(17): e90 - e90.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Yang, G. E. Holt, M. P. Velders, E. D. Kwon, and W. M. Kast
Murine Six-Transmembrane Epithelial Antigen of the Prostate, Prostate Stem Cell Antigen, and Prostate-specific Membrane Antigen: Prostate-specific Cell-Surface Antigens Highly Expressed in Prostate Cancer of Transgenic Adenocarcinoma Mouse Prostate Mice
Cancer Res., August 1, 2001; 61(15): 5857 - 5860.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Luo, D. J. Duggan, Y. Chen, J. Sauvageot, C. M. Ewing, M. L. Bittner, J. M. Trent, and W. B. Isaacs
Human Prostate Cancer and Benign Prostatic Hyperplasia: Molecular Dissection by Gene Expression Profiling
Cancer Res., June 1, 2001; 61(12): 4683 - 4688.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Xu, M. Kalos, J. A. Stolk, E. J. Zasloff, X. Zhang, R. L. Houghton, A. M. Filho, M. Nolasco, R. Badaró, and S. G. Reed
Identification and Characterization of Prostein, a Novel Prostate-specific Protein
Cancer Res., February 1, 2001; 61(4): 1563 - 1568.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. D. Wolfgang, M. Essand, J. J. Vincent, B. Lee, and I. Pastan
TARP: A nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor gamma chain locus
PNAS, August 15, 2000; 97(17): 9437 - 9442.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.